Drug repurposing and emerging adjunctive treatments for schizophrenia
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Drug repurposing and emerging adjunctive treatments for schizophrenia
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 7, Pages 1049-1067
Publisher
Informa Healthcare
Online
2015-04-13
DOI
10.1517/14656566.2015.1032248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Maintenance Treatment With Varenicline for Smoking Cessation in Patients With Schizophrenia and Bipolar Disorder
- (2014) A. Eden Evins et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Normalizing Effects of EVP-6124, an Alpha-7 Nicotinic Partial Agonist, on Event-Related Potentials and Cognition
- (2014) SHELDON H. PRESKORN et al. Journal of Psychiatric Practice
- Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled study
- (2014) Mohammad-Reza Khodaie-Ardakani et al. PSYCHIATRY RESEARCH
- A Double-Blind Randomized Controlled Trial of Oxytocin Nasal Spray and Social Cognition Training for Young People With Early Psychosis
- (2014) Cristina Cacciotti-Saija et al. SCHIZOPHRENIA BULLETIN
- A pilot six-week randomized controlled trial of oxytocin on social cognition and social skills in schizophrenia
- (2014) Clare M. Gibson et al. SCHIZOPHRENIA RESEARCH
- A randomized, controlled trial of omega-3 fatty acids plus an antioxidant for relapse prevention after antipsychotic discontinuation in first-episode schizophrenia
- (2014) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: A double blind, randomized, controlled trial
- (2014) Fang Liu et al. SCHIZOPHRENIA RESEARCH
- Effect of Bitopertin, a Glycine Reuptake Inhibitor, on Negative Symptoms of Schizophrenia
- (2014) Daniel Umbricht et al. JAMA Psychiatry
- Cardiometabolic Risk in Patients With First-Episode Schizophrenia Spectrum Disorders
- (2014) Christoph U. Correll et al. JAMA Psychiatry
- Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
- (2014) Gilda Kianimehr et al. DARU-Journal of Pharmaceutical Sciences
- A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
- (2013) David H Adams et al. BMC Psychiatry
- N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
- (2013) Mehdi Farokhnia et al. CLINICAL NEUROPHARMACOLOGY
- Alternative pharmacologic targets for the treatment of schizophrenia
- (2013) Seiya Miyamoto et al. CURRENT OPINION IN PSYCHIATRY
- Repurposed Drugs for the Treatment of Schizophrenia and Bipolar Disorders
- (2013) J. Bumb et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Effects of raloxifene on cognition in postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial
- (2013) Elena Huerta-Ramos et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
- (2013) Stefan Leucht et al. LANCET
- A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia
- (2013) Jeffrey A Lieberman et al. NEUROPSYCHOPHARMACOLOGY
- Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia
- (2013) Sungwon Roh et al. PSYCHOPHARMACOLOGY
- Efficacy of Anti-inflammatory Agents to Improve Symptoms in Patients With Schizophrenia: An Update
- (2013) I. E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Adjunctive Use of Nonsteroidal Anti-inflammatory Drugs for Schizophrenia: A Meta-analytic Investigation of Randomized Controlled Trials
- (2013) Masahiro Nitta et al. SCHIZOPHRENIA BULLETIN
- Definition and description of schizophrenia in the DSM-5
- (2013) Rajiv Tandon et al. SCHIZOPHRENIA RESEARCH
- Targeting alpha-7 nicotinic neurotransmission in schizophrenia: A novel agonist strategy
- (2013) Stephen I. Deutsch et al. SCHIZOPHRENIA RESEARCH
- Randomized Multicenter Investigation of Folate Plus Vitamin B12Supplementation in Schizophrenia
- (2013) Joshua L. Roffman et al. JAMA Psychiatry
- A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
- (2013) H Bentsen et al. Translational Psychiatry
- Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia
- (2012) Amirhossein Modabbernia et al. CNS DRUGS
- Clozapine resistance—Augmentation strategies
- (2012) Jari Tiihonen et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- A Multicenter, Add-On Randomized Controlled Trial of Low-Dosed-Serine for Negative and Cognitive Symptoms of Schizophrenia
- (2012) Mark Weiser et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder
- (2012) Jill M. Williams et al. JOURNAL OF CLINICAL PSYCHIATRY
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment
- (2012) Imran B Chaudhry et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
- (2012) S Miyamoto et al. MOLECULAR PSYCHIATRY
- Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
- (2012) Joanne Y.T. Leung et al. PHARMACOLOGY & THERAPEUTICS
- Estrogen augmentation in schizophrenia: A quantitative review of current evidence
- (2012) Marieke J.H. Begemann et al. SCHIZOPHRENIA RESEARCH
- Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia
- (2012) F M Leweke et al. Translational Psychiatry
- Meta-Analysis of the Efficacy of Adjunctive NMDA Receptor Modulators in Chronic Schizophrenia
- (2011) Surendra P. Singh et al. CNS DRUGS
- Clozapine resistance: Augmentation strategies
- (2011) Stefano Porcelli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia
- (2011) Judith Usall et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Grand challenges in global mental health
- (2011) Pamela Y. Collins et al. NATURE
- Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine
- (2011) Andreas Meyer-Lindenberg et al. NATURE REVIEWS NEUROSCIENCE
- Adjunctive Varenicline Treatment with Antipsychotic Medications for Cognitive Impairments in People with Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
- (2011) Joo-Cheol Shim et al. NEUROPSYCHOPHARMACOLOGY
- AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
- (2011) C. Hiemke et al. PHARMACOPSYCHIATRY
- Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review
- (2011) Iris E. Sommer et al. SCHIZOPHRENIA BULLETIN
- Folate supplementation in schizophrenia: A possible role for MTHFR genotype
- (2011) Michele Hill et al. SCHIZOPHRENIA RESEARCH
- Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia
- (2011) Cort A. Pedersen et al. SCHIZOPHRENIA RESEARCH
- Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
- (2010) G. Paul Amminger et al. ARCHIVES OF GENERAL PSYCHIATRY
- Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients
- (2010) David Feifel et al. BIOLOGICAL PSYCHIATRY
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Past and Present Progress in the Pharmacologic Treatment of Schizophrenia
- (2010) John M. Kane et al. JOURNAL OF CLINICAL PSYCHIATRY
- Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders
- (2010) Wijnand Laan et al. JOURNAL OF CLINICAL PSYCHIATRY
- From maps to mechanisms through neuroimaging of schizophrenia
- (2010) Andreas Meyer-Lindenberg NATURE
- Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia
- (2010) Jayashri Kulkarni et al. PSYCHONEUROENDOCRINOLOGY
- High dose D-serine in the treatment of schizophrenia
- (2010) Joshua T. Kantrowitz et al. SCHIZOPHRENIA RESEARCH
- Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment
- (2010) Norbert Müller et al. SCHIZOPHRENIA RESEARCH
- Estrogens and men with schizophrenia: Is there a case for adjunctive therapy?
- (2010) Jayashri Kulkarni et al. SCHIZOPHRENIA RESEARCH
- Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
- (2010) Jean-Pierre Lindenmayer et al. SCHIZOPHRENIA RESEARCH
- Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
- (2009) Dagmar Koethe et al. BRITISH JOURNAL OF PSYCHIATRY
- First Administration of Cytidine Diphosphocholine and Galantamine in Schizophrenia
- (2009) Stephen I. Deutsch et al. CLINICAL NEUROPHARMACOLOGY
- A randomized, double-blind, placebo-controlled comparison study of sarcosine ( N-methylglycine) and d-serine add-on treatment for schizophrenia
- (2009) Hsien-Yuan Lane et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats
- (2009) Alexandre Seillier et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- A Double-Blind, Randomized Study of Minocycline for the Treatment of Negative and Cognitive Symptoms in Early-Phase Schizophrenia
- (2009) Yechiel Levkovitz et al. JOURNAL OF CLINICAL PSYCHIATRY
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder
- (2009) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- The efficacy of lamotrigine in clozapine-resistant schizophrenia: A systematic review and meta-analysis
- (2009) Jari Tiihonen et al. SCHIZOPHRENIA RESEARCH
- Beneficial effects ofN-acetylcysteine in treatment resistant schizophrenia
- (2009) Mahmut Bulut et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Estrogen in Severe Mental Illness
- (2008) Jayashri Kulkarni et al. ARCHIVES OF GENERAL PSYCHIATRY
- N-Acetyl Cysteine as a Glutathione Precursor for Schizophrenia—A Double-Blind, Randomized, Placebo-Controlled Trial
- (2008) Michael Berk et al. BIOLOGICAL PSYCHIATRY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia
- (2008) Kristi A. Sacco et al. SCHIZOPHRENIA RESEARCH
- High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia
- (2008) M DYER et al. SCHIZOPHRENIA RESEARCH
- Once-weekly d-cycloserine effects on negative symptoms and cognition in schizophrenia: An exploratory study
- (2008) D GOFF et al. SCHIZOPHRENIA RESEARCH
- Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia
- (2007) Robert W. Buchanan et al. AMERICAN JOURNAL OF PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started